To investigate the molecular mechanism by which VPA down-regulated EGFR, ErbB2, and ErbB3 in pancreatic cancer cells, we next explored whether treatment with VPA might modulate EGFR, ErbB2, and ErbB3 mRNA levels. This evidence concerns the gene EGFR and familial pancreatic carcinoma.